
Aurinia Pharmaceuticals Inc (AUPH)’s latest performance is not what we had anticipated
On Friday, Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) was 13.47% up from the session before settling in for the closing price of $9.24. A 52-week range
On Friday, Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) was 13.47% up from the session before settling in for the closing price of $9.24. A 52-week range
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) started the day on Wednesday, with a price increase of 1.17% at $9.05, before settling in for the price of
Witnessing the stock’s movement on the chart, on Wednesday, Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) set off with pace as it heaved 3.49% to $9.19, before
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) kicked off on Friday, down -4.85% from the previous trading day, before settling in for the closing price of $9.07.
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) kicked off on Tuesday, down -0.55% from the previous trading day, before settling in for the closing price of $9.04.
On Tuesday, Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) was 1.61% up from the session before settling in for the closing price of $7.47. A 52-week range
On Tuesday, Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) was -11.69% drop from the session before settling in for the closing price of $8.47. A 52-week range
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) kicked off on Tuesday, up 2.81% from the previous trading day, before settling in for the closing price of $7.83.
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.